Malaria, Falciparum
16 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| artemether-lumefantrine for malaria, falciparum | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| artemether-lumefantrine + Mosquirixs for malaria, falciparum | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Atovaquone-Proguanil for malaria, falciparum | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Cabamiquine for malaria, falciparum | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Etofenprox-treated lesu for malaria, falciparum | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Factory-treated lesu for malaria, falciparum | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| M5717 200 mg + PYRONARIDINE for malaria, falciparum | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| M5717 330 mg + PYRONARIDINE for malaria, falciparum | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| M5717 500 mg + M5717 660 mg + PYRONARIDINE for malaria, falciparum | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| M5717 60 mg + PYRONARIDINE for malaria, falciparum | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| M5717 660mg + PYRONARIDINE for malaria, falciparum | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Matrix-M with RH5.2 VLP and/or R21 for malaria, falciparum | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Mosquirixs for malaria, falciparum | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Permethrin-treated lesu for malaria, falciparum | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| R21 in Matrix- M adjuvant vaccine for malaria, falciparum | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Soaked lesu for malaria, falciparum | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |